|1.||Katz, Naftale: 3 articles (11/2013 - 08/2008)|
|2.||Coelho, Paulo Marcos Zech: 3 articles (11/2013 - 08/2008)|
|3.||Araújo, Neusa: 2 articles (11/2013 - 08/2008)|
|4.||Mattos, Ana Carolina Alves de: 2 articles (12/2008 - 08/2008)|
|5.||Brandt, C T: 2 articles (07/2004 - 01/2001)|
|6.||Abdel-Monaem, G: 1 article (10/2015)|
|7.||El-Amir, A: 1 article (10/2015)|
|8.||Rabia, I: 1 article (10/2015)|
|9.||Farid, A: 1 article (10/2015)|
|10.||Vimieiro, Andréa Cássia Simões: 1 article (11/2013)|
01/01/1982 - "The authors conclude that oral oxamniquine in the prescribed dosage, has low toxicity and good therapeutic efficacy in children with chronic schistosomiasis mansoni."
01/01/1980 - "Therapeutic efficacy of oral oxamniquine in the toxemic form of schistosomiasis mansoni: treatment of eleven individuals from two families, and experimental study."
01/01/2000 - "IPraziquantel and oxamniquine both appear to be effective for the treatment of Schistosomiasis mansoni, although lower doses of oxamniquine (less than 30 milligrams per kilogram) may not be as effective."
01/01/1980 - "Serum levels and efficacy of oxamniquine in patients with Schistosomiasis mansoni following administration of a therapeutic dose."
01/01/1987 - "A double blind trial was set up to study the pulmonary effects of specific treatment with oxamniquine of 40 patients with chronic schistosomiasis mansoni. "
01/01/1981 - "[Efficacy of oxamniquine in Schistosoma mansoni bilharziasis in Madagascar in a hospital milieu]."
01/01/1989 - "This study is based of family heredograms, and takes into account the clinical form of schistosomiasis observed before treatment with oxamniquine. "
03/01/1976 - "Preliminary laboratory trials with oxamniquine as a prophylactic agent in schistosomiasis."
01/01/1975 - "Letter: Clinical trials with oxamniquine in the treatment of human mansonian schistosomiasis."
03/01/2008 - "Our objective was to identify the clinical forms of schistosomiasis among 109 patients in whom the disease had been diagnosed through direct fecal analysis and who had been medicated with oxamniquine at the time of the Plan for the Intensification of Schistosomiasis Control Actions (1998-2000). "
11/01/1993 - "These findings confirm the efficacy of oxamniquine at the skin phase of infection, and also show similarity with the immunization method that uses irradiated cercariae. "
06/26/1976 - "A trial of oral oxamniquine in the treatment of Schistosoma infection in children."
11/01/2006 - "Most Schistosoma mansoni infections are egg-negative after a single dose of oxamniquine. "
10/01/2005 - "Simultaneously, other infected groups were given oxamniquine, 70 and 140 days after infection. "
12/01/2003 - "On days 70 and 160 two other groups of infected mice were treated with 400 mg/kg of oxamniquine and portal pressure was measured 90 days later (160 and 250 days after infection). "
|4.||Body Weight (Weight, Body)
07/01/1982 - "Oxamniquine was given in single daily doses of 20 mg/kg of body weight for either two or three days and cured 50% and 85%, respectively, of subjects treated; ova excretion was reduced by 86%-93% for up to 12 months. "
11/01/1990 - "5067 individuals (50-80% of the local population) were treated with 20-40 mg oxamniquine per kg body weight during the rainy seasons of 1985 (Dalati) and 1986 (Agallu Metti). "
01/01/1987 - "The effects of a single dose (100 mg/kg-body weight of mouse) of oxamniquine on the worm's tegument and paranchyma in relation to the process of immunological granulomatous reaction of the host's liver are described under light and electron microscopy (EM). "
01/01/1982 - "48 (Group 1) were treated with a single oral dose of oxamniquine (20mg/kg body-weight) and 43 (Group 2) received the placebo. "
01/01/1982 - "In a further two campaigns oxamniquine was used (15 mg/kg body weight). "
|5.||Salmonella Infections (Salmonellosis)
01/01/1985 - "[Therapeutic efficacy of oral oxamniquine in the treatment of prolonged septicemic salmonellosis]."
05/01/1979 - "[Treatment of long-term salmonellosis with oxamniquine]."
01/01/1980 - "Observations of the treatment of mansoni schistosomiasis with oxamniquine: efficacy in children and in persistent salmonellosis; resistance of a strain of Schistosoma mansoni; hepatic toxicity and neurological side effects."
|7.||Immunoglobulin E (IgE)
|9.||Blood Proteins (Serum Proteins)
|2.||Drug Therapy (Chemotherapy)